🔎 Trials Near Me

Beranda › Penyakit Hati Steatotik › Florida › Miami

Uji klinis Penyakit Hati Steatotik di Miami, FL

16 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Menerima pesertaFase 3
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Menerima pesertaFase 3
  • 89bio Clinical Study Site, Miami
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Menerima pesertaFase 2
  • Evolution Clinical Trials, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Menerima pesertaFase 2
  • University of Miami Health System, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Menerima pesertaFase 2
  • Genoma Research Group, Inc., Miami
  • Med Research of Florida, LLC, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Menerima pesertaFase 3
  • Evolution Clinical Trials, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Menerima pesertaFase 3
  • Akero Clinical Study Site, Miami
  • Akero Clinical Study Site, Miami
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 3 lainnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Menerima pesertaFase 2
  • GSK Investigational Site, Miami
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 4 lainnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Menerima pesertaFase 2
  • GSK Investigational Site, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Menerima pesertaStudi observasional
  • Clinical Pharmacology of Miami, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Agu 2025 · NCT07122700

Uji klinis Penyakit Hati Steatotik di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.